Search Results - "Rezus, E"

Utility of different cardiovascular disease prediction models in rheumatoid arthritis by Purcarea, A, Sovaila, S, Udrea, G, Rezus, E, Gheorghe, A, Tiu, C, Stoica, V

“…Rheumatoid arthritis comes with a 30% higher probability for cardiovascular disease than the general population. Current guidelines advocate for early and…”
Get full text

Patients' perspectives and motivators to participate in clinical trials with novel therapies for rheumatoid arthritis by Udrea, G, Dumitrescu, B, Purcarea, M, Balan, I, Rezus, E, Deculescu, D

“…Successful advances in the treatment of rheumatoid arthritis rely on enrolment of patients into clinical trials with novel agents. The aim of this study was to…”
Get full text

Antibacterial antibodies for some enterobacteria in sera of patients with reactive arthritis and other rheumatoid diseases by Constantiniu, S, Romaniuc, A, Chiriac, R, Berea, C, Kalis, O, Rezus, E, Mutica, M

“…The presence of the specific antibodies for some enterobacteria--Yersinia, Salmonella and Shigella was investigated in patients hospitalized in the period…”
Get full text

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials by Neuwelt, C. Michael, Hobbs, Kathryn, Galateanu, Catrinel, Beaudot, Carolyn, Kilgallen, Brian, Batalov, A., Duca, L., Horak, P., Monova, D., Otsa, K., Popova, T., Radulescu, F., Rednic, S., Vezikova, N., Vitek, P., Zainea, C., Huang, C., Kang, S., Lai, N., Shim, S., Zapata, F. Avila, Cavalcanti, F., Agmon‐Levin, N., Kadel, J., Levy, Y., Mevorach, D., Rosner, I., Shobha, V., Zisman, D., Ayesu, K., Chi, J., Clowse, M., Dao, K., Diab, I., Dikranian, A., El‐Shahawy, M., Kao, A., Katz, R., Lawrence‐Ford, T., Merrill, J., Niemer, G., Pickrell, P., Rothfield, N., Snyder, A., Striebich, C., Vo, Q., Littlejohn, G., Perez, L.Carreno, Chakravarty, K., Gonzales, F. Diaz, Davies, K., Doria, A., Fernández‐Nebro, A., Govoni, M., Hachulla, E., Muñoz‐Fernández, S., Pena‐Sagredo, J., Schmidt, R. E., Ucar‐Angulo, E., Westhovens, R., Yee, C. S., Bazela, B., Chudzik, D., Geher, P., Ionescu, R., Kwiatkowska, B., Leszczynski, P., Nalotov, S., Pavel, M., Raskina, T., Rezus, E., Semen, T., Bonfiglioli, R., Baker, M., Chow, A., Clay, C., Conaway, D., Denburg, J., Escalante, A., Fortin, I., Goddard, D., Hemaiden, A., Kalunian, K., Lafyatis, R., Mease, P., Mehta, C., Nascimento, J., Saadeh, C., Valenzuela, G., Alten, R., Braun, J., Dival, L., Espinosa, G., Fernandez, I. Figueroa, Gordon, C., Jacobi, A., Pego‐Reigosa, J. M., Rubbert‐Roth, A., Schroeder, J., Schwarting, A.

“…Objective Epratuzumab, a monoclonal antibody that targets CD22, modulates B cell signaling without substantial reductions in the number of B cells. The aim of…”
Get full text

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis by Becker, Mike, Graf, Nicole, Sauter, Rafael, Allanore, Yannick, Curram, John, Denton, Christopher P, Khanna, Dinesh, Matucci-Cerinic, Marco, de Oliveira Pena, Janethe, Pope, Janet E, Distler, Oliver

“…Mortality and worsening of organ function are desirable endpoints for clinical trials in systemic sclerosis (SSc). The aim of this study was to identify…”
Get more information

Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis by Velauthapillai, A, Bootsma, M F R, Bruni, C, Bergmann, C, Matucci-Cerinic, M, Launay, D, Riemekastan, G, Garzanova, L, Airò, P, Rezus, E, da Silva, J A P, Del Galdo, F, Hunzelmann, N, Chung, L S, Krasowska, D, Distler, O, van den Ende, C H M, Vonk, M C

“…Hypothesizing that early treatment yields improved prognosis, we aimed to investigate how the timing of immunosuppressive treatment relates to interstitial…”
Get full text

Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort by Hughes, Michael, Huang, Suiyuan, Alegre-Sancho, Juan Jose, Carreira, Patricia E, Engelhart, Merete, Hachulla, Eric, Henes, Joerg, Kerzberg, Eduardo, Pozzi, Maria Rosa, Riemekasten, Gabriela, Smith, Vanessa, Szücs, Gabriella, Vanthuyne, Marie, Zanatta, Elisabetta, Distler, Oliver, Gabrielli, Armando G, Hoffmann-Vold, Anna-Maria, Steen, Virginia D, Khanna, Dinesh

“…The early trajectory of skin fibrosis provides insights into the disease course of systemic sclerosis (SSc) including mortality; however, little is known about…”
Get full text

268 Autoantibodies dictate clinical manifestations in patients with systemic lupus erythematosus by Burlui, A, Cardoneanu, A, Rezus, E

“…Background and aimsSystemic Lupus Erythematosus (SLE) is known for its multifaceted clinical features and complex immune disturbance. Numerous studies have…”
Get full text

P139 Articular manifestations in inflammatory bowel disease – results from Northeastern Romania by Cardoneanu, A., Rezus, E., Gavrilescu, O., Cijevschi-Prelipcean, C., Dranga, M., Badescu, A., Drug, V., Stanciu, C., Trifan, A., Mihai, C.

Get full text

Patients'perspectives and motivators to participate in clinical trials with novel therapies for rheumatoid arthritis by Udrea, G, Dumitrescu, B, Purcarea, M, Balan, I, Rezus, E, Deculescu, D

“…Background and Purposes–Successful advances in the treatment of rheumatoid arthritis rely on enrolment of patients into clinical trials with novel agents. The…”
Get full text

The antioxidant systems in rheumatoid polyarthritis by Chiriac, R, Rezuş, E, Florică, B, Chiriac, C, Bucur, B, Popârda, O, Mancaş, G, Palamaru, I

“…The inflammatory process from rheumatoid arthritis (RA) is marked by complexity, maintenance and destruction. The inflammatory lesions are induced by oxygen…”
Get more information

Intrapleural analgesia via a percutaneous catheter by Boiculese-Rezuş, E, Vereş, L, Mihăescu, T

Get more information